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Immunosuppression of any kind is a known risk factor for infection with Listeria monocytogenes (L. monocytogenes). Particularly,
patients with impaired liver function are at increased risk of developing an aggravated course of infection with this bacterial
pathogen (see Nolla-Salas et al.; 2002 and Cabellos et al.; 2008). It is a well-known pathogen in immunocompromised patients,
but has only seldom been reported following orthotopic liver transplantation. Invasion of the central nervous system presenting
as meningitis or meningoencephalitis and bacteremia are the principal clinical manifestations of listerial infections (see Brouwer
et al.; 2006). We present an account of a case of a patient who developed L. monocytogenes meningitis during the early period after
liver transplantation.
1.CaseReport
We report the case of a 57-year old man diagnosed with liver
cirrhosis Child-Turcotte-Pugh C resulting from chronic hep-
atitisC.HeunderwentlivertransplantationinJune2007,ata
transplantation center in Germany. The operation itself was
uneventfulandnocomplicationswerereportedaftersurgery.
Furthermorethepreexistenthepato-renalsyndromeresolved
after transplantation. His immunosuppressive medication
included tacrolimus (2 × 4mg), mycophenolate-mofetil
(2 × 1g) and prednisolone (10mg).
In August 2007 the patient was admitted to our hospital
because of impaired consciousness since the previous day. In
our emergency ward elevated body temperature was noticed
and shortly after admittance the patient suﬀered a focal
epileptic seizure accompanied by worsening of the mental
status and the respiratory situation. He became unconscious
and had to be transferred to our intensive care unit. For
further evaluation a lumbar puncture was performed. The
laboratory-chemical analysis indicated bacterial meningitis
(see Table 1). In the microscopical analysis gram-positive
rods were observed. A parenteral antibiotic therapy with
ampicillin (4g three times daily) and gentamicin (5mg/kg)
was initiated. In the following days, L. monocytogenes grewin
culture of cerebrospinal ﬂuid (CSF). The patient responded
well to the above-mentioned therapy. The elevated lab-
oratory parameters of inﬂammation (CRP on admission:
234mg/l, CRP hospital day 6: 44mg/l) normalized and the
clinical status improved. In a followup lumbar puncture on
day 6 of the clinical illness the cell count was normalizing.
The patient was transferred to the normal ward after his
clinical situation improved. He was discharged on the 25th
day following admittance. Before the infection occurred
there was no exposure to potentially contaminated food
known.
2. Discussion
Listeria monocytogenes is a ubiquitous pathogen in the envi-
ronment, capable of causing human and animal infection.
Althoughuncommoninhumans,itcausesillnessinsporadic
and epidemic forms throughout the world. The pathogen
is a facultative intracellular, aerobic, facultatively anaerobic
gram-positive rod [1]. The organism is normally found in
soil and decaying vegetable material. Listeria is exceptionally
resistant to environmental conditions and able to grow in
temperatures ranging from 4◦Ct o3 7
◦C. It is most often2 Case Reports in Medicine
Table 1: Cerebrospinal ﬂuid analysis.
Reference
range,
adults
On
admission
Hospital
day 6
T o t a lc e l lc o u n t( p e rm m 3) 0–5 1220 724
Proteine (mg/dl) 5–55 519 311
Glucose (mg/dl) 50–57 36 101
Lactate (mmol/l) 16.6 4.7
transmitted to humans via contaminated foods like milk,
cheese, undercooked meat, or uncooked vegetables. The
pathogenhasalsobeenisolatedfromasymptomatichumans.
About one to ﬁve percent of healthy individuals are fecal
excretors of Listeria species [2]. The Center of Disease
Control and Prevention (CDC) declares that in the United
States an estimated 2,500 persons become seriously ill with
listeriosis each year; of these 500die.
After the introduction of the Haemophilus inﬂuenzae
type b conjugate vaccine in the USA, meningitis caused by
L. monocytogenes became the fourth most common cause
of bacterial meningitis, following Streptococcus pneumoniae,
Neisseria meningitides and group B streptococcus [3].
Most of the systemic invasive infections with Listeria are
in individuals with one or more predisposing conditions.
Theriskfactorsaremainlypregnancy,corticosteroidtherapy,
other immunosuppressive therapy, and age. In a study from
Finland seventy four cases of systemic listeriosis were anal-
ysed. Of these patients, 66% had an underlying disease, most
commonly malignancy, diabetes mellitus, or renal transplan-
tation, and 43% had received immunosuppressive therapy
within one week before onset of listeriosis. Bacteremia and
central nervous system infections were the most common
clinical entities; both accounted for 43% of cases [4]. In
a review analysing Listeria-meningitis-meningoencephalitis
outside of pregnancy, hematologic malignancy and kidney
transplantation were the leading predisposing factors. But
in 36% of patients no underlying diseases were detectable.
Listeriosis occurred throughout life, with a higher incidence
before the age of 3 and after the age of 45–50 years [5].
Thirteen cases of spontaneous bacterial peritonitis due to
L. monocytogenes in individuals with cirrhosis suggest that
livercirrhosisisalsoasigniﬁcantriskfactorforlisteriosis[6].
According to a Spanish study bacterial meningitis in
cirrhotic patients was associated with a high mortality and
a large number of complications; a case fatality rate of 53.1%
was observed. Of the classic pathogens, L. monocytogenes
was more prevalent than in other immunocompromised
patients. The authors suggest that this could be the result of
the easy translocation of the organism into the bloodstream
from the gastrointestinal tract [7]. According to a review
of the literature, it seems that liver disease is not the
only predisposing factor of infection with Listeria: liver
transplantation is also associated with an elevated risk of
infection with this bacterial pathogen. The authors collected
thirteen cases of listeriosis following liver transplantation, in
which four occurrences of meningitis were reported [8–21].
The case report itself referred to a case of a patient with
central nervous system involvement following orthotopic
liver transplantation; L. monocytogenes was grown in culture
from the CSF and blood [8]. In another case report a 29-
year old man diagnosed with autoimmune hepatitis suﬀered
bacteremia and peritonitis in the early postoperative period
after cadaveric liver transplantation [22]. Data from the
literature show that listeriosis can present within days to
years after transplantation [9, 10]. Nosocomial acquisition
in the present case is unlikely because there were no further
cases of listeriosis in our hospital at the same time. There
was also no evidence that the transmission was caused by the
donor. We speculate that the source of infection is through
the intestinal tract following previous enteric colonization
probably after ingestion of contaminated food products.
Even though there are still no satisfactory data regarding
the incidence of Listeria infection following liver transplan-
tation it seems that patients after transplantation suﬀer a
greater risk to develop an aggravated course of infection with
this pathogen. Including this case there are 16 reported cases
of listeriosis after liver transplantation (see Table 2).
Theclinicalsignsofmeningitis causedbyListeriainclude
fever, headache and altered mental status and the signs of
Listeria meningitis do not for the most part diﬀer from
those found in patients with community-acquired non-
listerialbacterialmeningitis[23].Allofthetypicalsymptoms
were present in 43% of the patients. Almost all patients
presented with at least two of the four classical symptoms,
headache, fever, neck stiﬀness, and altered mental status.
The above-mentioned symptoms of bacterial meningitis
were reported equally in meningitis patients due to other
causes [24]. On the contrary in some previous reports
an atypical course of meningitis was reported. In a study
by Mylonakis et al., patients with Listeria infection had a
signiﬁcantly lower incidence of meningeal signs compared
with patients with acute meningitis due to other bacterial
pathogens. The CSF proﬁle was signiﬁcantly less likely to
have a high cell count or a high protein concentration [5].
The course of meningitis ranges from mild illness with
fever and changes of mental status to a fulminant course
with coma. A subacute presentation with cranial nerve
palsies, lymphocytic pleocytosis, elevated CSF protein and
low glucose may mimic tuberculous or fungal meningitis.
Additionally focal signs can be present. Beside cranial nerve
abnormalities, there may be ataxia, tremors, hemiplegia and
deafness. In the later course seizures may occur [5]. In a large
proportion of patients, symptoms may be present for more
than 4 days. In the literature, meningitis caused by Listeria is
characterized by high case-fatality rates (24%–62%) due to
the occurrence in the elderly and the immunocompromised
[25]. A recent prospective study demonstrates a mortality
rate of 17% [23].
We present a case of Listeria meningitis shortly after
orthotopic liver transplantation. Because of the low inci-
dence and the high mortality rate of Listeria infection,
physicians must be aware of this pathogen most notably
in immunocompromised patients, particularly because the
therapy of Listeria meningitis diverges from the “normal”
regime used for other bacterial pathogens causing menin-
gitis. Third-generation cephalosporins are the beta-lactamsCase Reports in Medicine 3
Table 2: Cases of listeria infection following liver transplantation.
Age (yr) Sex Time post LTX Clinical presentation Treatment Outcome Ref
53 M 5d Meningitis with headache, mental decline Ampicillin Survived [8]
66 F 32mo Fever, hypotension, bacteremia Ampicillin Survived [9]
39 F 7d Fever, abdominal pain, bacteremia Ampicillin Survived [10]
66 F 32mo Fever, right ﬂank pain, anorexia, bacteremia Ampicillin Survived [11]
39 F 7d Fever, abdominal pain, bacteremia Ampicillin Survived [12]
55 F 4mo Fever, abdominal pain, bacteremia TMP-SMX Survived [13]
57 F 20mo Bacteremia, hepatitis Ampicillin Survived [14]
56 F 8mo Bacteremia, hepatitis Ampicillin, Gentamicin Survived [15]
41 F 10mo Endocarditis, bacteremia, hepatitis, pulmonary emboli Ampicillin, Gentamicin Survived [16]
47 F NR Peritonitis, bacteremia Ampicillin, Amikacin Survived [17]
11mo M 7d Meningitis, epididymitis, orchitis Ampicillin Survived [18]
NR NR 14d Meningitis NR Survived [19]
67 F 21d Meningitis Ampicillin Died [20]
13 F 4mo Meningitis Ampicllin, Tetracycline Died [21]
29 M 4d Fever, abdominal pain, cholestasis Ampicillin Survived [22]
Abbreviations: TMP-SMX: trimethoprim-sulfamethoxazole; NR: not reported.
of choice in the empiric treatment of meningitis. These
drugs have potent activity against all the major pathogens
of bacterial meningitis with the notable exception of
L. monocytogenes since Listeria has an innate resistance to
cephalosporin antibiotics. The treatment of choice against
Listeria has traditionally been ampicillin (2g every four
hours) since resistance to this drug is rare [26]. Some
authors recommend the addition of gentamicin to ampicillin
treatment on the basis of the synergistic eﬀect observed in
vitroinanimalmodels,butgentamicinispoorinpenetrating
the intracellular compartment and the CSF and is a well-
recognized nephrotoxic agent. Ampicillin is given for two to
four weeks in immunocompetent patients and for four to
eight weeks in immunocompromised patients. Gentamicin
is given for 10 to 14 days until the patient improves; in poor
responders, it can be given for up to three weeks.
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